The SAM fluorescent immunoassay market is expected to grow from US$ 129.71 million in 2021 to US$ 168.65 million by 2028; it is estimated to grow at a CAGR of 3.8% from 2021 to 2028.
Fluorescent immunoassays are diagnostic tools for quality control and the quantity-specific detection of antigens and antibodies. The technique derives from the fundamental immunological concept of antigen-antibody binding. These are used in screening to quantify the production or inhibition of antigens/haptens associated with a disease target. These antigens or haptens are characteristic of the disease process and are mediated by the target, such as cytokines or growth factors. Cell therapy is the practice of using cellular material to produce the desired effect in vitro or in vivo through their biological activities and properties. The cells used for the treatments can be classified as either allogeneic or autologous. Modern cell-based therapies also include regenerating human cells, tissue, or organs. The basis of the cells used comes from the stem and progenitor cells, mature and functionally differentiated cells, or artificially produced tissue. Fluorescence-activated cell sorting (FACS) is a highly flexible technique with many options for stem cell sorting. It is also the only way to isolate a particular stem cell population using multiple internal and external markers. FACS is a specialized type of flow cytometry that sorts a heterogeneous mixture of cells based on each cell's specific light scatter and fluorescence properties. Cells are first tagged with fluorescent antibodies that bind to relevant proteins on target cells. Single cells pass a laser beam, and a detector measures fluorescence, forward scattered light (FSC), and side spread light (SSC). FSC and SSC are used to determine the size of the cell. Fluorescence at multiple wavelengths can be detected simultaneously but depends on the instrument's specific lasers, filters, and detectors. The cells are then physically sorted into different bins based on captured measurements and user-entered parameters. Fluorescence-activated cell sorting allows for current and future cell isolation needs for efficient stem cell research. Thus, there is a growing demand for fluorescent immunoassays for providing quality and the quantity-specific detection of antigens and antibodies.
With new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the SAM fluorescent immunoassay market at a notable CAGR during the forecast period.
Abbott, BD, bioMerieux SA, Danaher, F. Hoffmann-La Roche Ltd., Ortho Clinical Diagnostics Holdings plc, Quidel Corporation, Siemens AG, Sysmex Corporation, and Thermo Fisher Scientific Inc. are among the leading companies operating in the SAM fluorescent immunoassay market.
Fluorescent immunoassays are diagnostic tools for quality control and the quantity-specific detection of antigens and antibodies. The technique derives from the fundamental immunological concept of antigen-antibody binding. These are used in screening to quantify the production or inhibition of antigens/haptens associated with a disease target. These antigens or haptens are characteristic of the disease process and are mediated by the target, such as cytokines or growth factors. Cell therapy is the practice of using cellular material to produce the desired effect in vitro or in vivo through their biological activities and properties. The cells used for the treatments can be classified as either allogeneic or autologous. Modern cell-based therapies also include regenerating human cells, tissue, or organs. The basis of the cells used comes from the stem and progenitor cells, mature and functionally differentiated cells, or artificially produced tissue. Fluorescence-activated cell sorting (FACS) is a highly flexible technique with many options for stem cell sorting. It is also the only way to isolate a particular stem cell population using multiple internal and external markers. FACS is a specialized type of flow cytometry that sorts a heterogeneous mixture of cells based on each cell's specific light scatter and fluorescence properties. Cells are first tagged with fluorescent antibodies that bind to relevant proteins on target cells. Single cells pass a laser beam, and a detector measures fluorescence, forward scattered light (FSC), and side spread light (SSC). FSC and SSC are used to determine the size of the cell. Fluorescence at multiple wavelengths can be detected simultaneously but depends on the instrument's specific lasers, filters, and detectors. The cells are then physically sorted into different bins based on captured measurements and user-entered parameters. Fluorescence-activated cell sorting allows for current and future cell isolation needs for efficient stem cell research. Thus, there is a growing demand for fluorescent immunoassays for providing quality and the quantity-specific detection of antigens and antibodies.
With new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the SAM fluorescent immunoassay market at a notable CAGR during the forecast period.
SAM Fluorescent Immunoassay Market Segmentation
The SAM fluorescent immunoassay market is segmented into product type, application, end user, and country. Based on product type, the market is segmented into ELISA, rapid lateral flow immunoassay, and others. The ELISA segment dominated the market in 2021 and is expected to register the highest during the forecast period. Based on application, the market is segmented into infectious diseases, oncology, cardiovascular diseases, and others. The infectious disease segment dominated the market in 2021 and is expected to register the highest CAGR during the forecast period. Based on end user, the market is segmented into hospitals & clinics, diagnostic centers, pharmaceutical & biotechnology companies, academic & research institutes, and others. The hospitals and clinics segment dominated the market in 2021 and is expected to register the highest CAGR during the forecast period. Based on country, the SAM fluorescent immunoassay market is segmented into Brazil, Argentina, and the Rest of SAM.Abbott, BD, bioMerieux SA, Danaher, F. Hoffmann-La Roche Ltd., Ortho Clinical Diagnostics Holdings plc, Quidel Corporation, Siemens AG, Sysmex Corporation, and Thermo Fisher Scientific Inc. are among the leading companies operating in the SAM fluorescent immunoassay market.
Table of Contents
1. Introduction1.1 Study Scope
1.2 Research Report Guidance
1.3 Market Segmentation
1.3.1 SAM Fluorescent Immunoassay Market - By Product Type
1.3.2 SAM Fluorescent Immunoassay Market - By Application
1.3.3 SAM Fluorescent Immunoassay Market - By End User
1.3.4 SAM Fluorescent Immunoassay Market - By Country
2. Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. SAM Fluorescent Immunoassay Market - Market Landscape
4.1 Overview
4.2 SAM PEST Analysis
4.3 Expert Opinions
5. SAM Fluorescent Immunoassay Market - Key Market Dynamics
5.1 Market Drivers
5.1.1 Growing Prevalence of Chronic Diseases
5.1.2 Increasing Demand for Cell Therapies
5.2 Market Restraints
5.2.1 Disadvantages of Fluorescent Immunoassays
5.3 Market Opportunities
5.3.1 Extensive Usage in Cancer Diagnostics
5.4 Future Trends
5.4.1 Increase in Development of Fluorescent Dyes and Instruments
5.5 Impact Analysis
6. Fluorescent Immunoassay Market - SAM Analysis
6.1 SAM Fluorescent Immunoassay Marker Revenue Forecast and Analysis
7. SAM Fluorescent Immunoassay Market Analysis - By Product Type
7.1 Overview
7.2 SAM Fluorescent Immunoassay Market Share by Product Type - 2021 & 2028 (%)
7.3 ELISA
7.3.1 Overview
7.3.2 ELISA: Fluorescent Immunoassay Market Revenue and Forecast to 2028 (USD Million)
7.4 Rapid Lateral Flow Immunoassay
7.4.1 Overview
7.4.2 Rapid Lateral Flow Immunoassay: Fluorescent Immunoassay Market Revenue and Forecast to 2028 (USD Million)
7.5 Others
7.5.1 Overview
7.5.2 Others: Fluorescent Immunoassay Market Revenue and Forecast to 2028 (USD Million)
8. SAM Fluorescent Immunoassay Market Analysis - By Application
8.1 Overview
8.2 SAM Fluorescent Immunoassay Market Share by Application - 2021 & 2028 (%)
8.3 Infectious Diseases
8.3.1 Overview
8.3.2 Infectious Diseases: Fluorescent Immunoassay Market Revenue and Forecast to 2028 (USD Million)
8.4 Oncology
8.4.1 Overview
8.4.2 Oncology: Fluorescent Immunoassay Market Revenue and Forecast to 2028 (USD Million)
8.5 Cardiovascular Disease
8.5.1 Overview
8.5.2 Cardiovascular Disease: Fluorescent Immunoassay Market Revenue and Forecast to 2028 (USD Million)
8.6 Others
8.6.1 Overview
8.6.2 Others: Fluorescent Immunoassay Market Revenue and Forecast to 2028 (USD Million)
9. SAM Fluorescent Immunoassay Market Analysis - By End User
9.1 Overview
9.2 SAM Fluorescent Immunoassay Market Share by End User - 2021 & 2028 (%)
9.3 Hospitals & Clinics
9.3.1 Overview
9.3.2 Hospitals & Clinics: Fluorescent Immunoassay Market Revenue and Forecast to 2028 (USD Million)
9.4 Diagnostic Centers
9.4.1 Overview
9.4.2 Diagnostic Centers: Fluorescent Immunoassay Market Revenue and Forecast to 2028 (USD Million)
9.5 Pharmaceutical & Biotechnology Companies
9.5.1 Overview
9.5.2 Pharmaceutical & Biotechnology Companies: Fluorescent Immunoassay Market Revenue and Forecast to 2028 (USD Million)
9.6 Academic & Research Institutes
9.6.1 Overview
9.6.2 Academic & Research Institutes: Fluorescent Immunoassay Market Revenue and Forecast to 2028 (USD Million)
9.7 Others
9.7.1 Overview
9.7.2 Others: Fluorescent Immunoassay Market Revenue and Forecast to 2028 (USD Million)
10. SAM Fluorescent Immunoassay Market Analysis - By Country
10.1 Overview
10.1.1 SAM Fluorescent Immunoassay Market Revenue and Forecasts to 2028, By Country (%)
10.1.1.1 Brazil: Fluorescent Immunoassay Market Revenue and Forecasts to 2028 (USD Million)
10.1.1.1.1 Overview
10.1.1.1.2 Brazil: Fluorescent Immunoassay Market Revenue and Forecasts to 2028 (USD Million)
10.1.1.1.3 Brazil: Fluorescent Immunoassay Market, by Product Type - Revenue and Forecast to 2028 (USD Million)
10.1.1.1.4 Brazil: Fluorescent Immunoassay Market, by Application - Revenue and Forecast to 2028 (USD Million)
10.1.1.1.5 Brazil: Fluorescent Immunoassay Market, by End User - Revenue and Forecast to 2028 (USD Million
10.1.1.2 Argentina Fluorescent Immunoassay Market Revenue and Forecasts to 2028 (USD Million)
10.1.1.2.1 Overview
10.1.1.2.2 Argentina Fluorescent Immunoassay Market Revenue and Forecasts to 2028 (USD Million)
10.1.1.2.3 Argentina: Fluorescent Immunoassay Market, by Product Type - Revenue and Forecast to 2028 (USD Million)
10.1.1.2.4 Argentina: Fluorescent Immunoassay Market, by Application - Revenue and Forecast to 2028 (USD Million)
10.1.1.2.5 Argentina: Fluorescent Immunoassay Market, by End User - Revenue and Forecast to 2028 (USD Million)
10.1.1.3 Rest of SAM: Fluorescent Immunoassay Market- Revenue and Forecast to 2028 (USD Mn)
10.1.1.3.1 Overview
10.1.1.3.2 Rest of SAM: Fluorescent Immunoassay Market- Revenue and Forecast to 2028 (USD Mn)
10.1.1.3.3 Rest of SAM: Fluorescent Immunoassay Market, by Product Type - Revenue and Forecast to 2028 (USD Million)
10.1.1.3.4 Rest of SAM: Fluorescent Immunoassay Market, by Application - Revenue and Forecast to 2028 (USD Million)
10.1.1.3.5 Rest of SAM: Fluorescent Immunoassay Market, by End User - Revenue and Forecast to 2028 (USD Million)
11. Industry Landscape
11.1 Overview
11.2 Organic Developments
11.2.1 Overview
11.3 Inorganic Developments
11.3.1 Overview
12. Company Profiles
12.1 F. Hoffmann-La Roche Ltd.
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Thermo Fisher Scientific Inc.
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Abbott
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 BD
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Danaher
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 bioMerieux SA
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Sysmex Corporation
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 Siemens AG
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 Ortho Clinical Diagnostics Holdings plc
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments
12.10 Quidel Corporation
12.10.1 Key Facts
12.10.2 Business Description
12.10.3 Products and Services
12.10.4 Financial Overview
12.10.5 SWOT Analysis
12.10.6 Key Developments
13. Appendix
13.1 About the Publisher
13.2 Glossary of Terms
List of Figures
Figure 1. SAM Fluorescent Immunoassay Market Segmentation
Figure 2. SAM Fluorescent Immunoassay Market - By Country
Figure 3. SAM Fluorescent Immunoassay Market Overview
Figure 4. SAM Fluorescent Immunoassay Market, By Product Type
Figure 5. SAM Fluorescent Immunoassay Market, By Country
Figure 6. SAM America PEST Analysis
Figure 7. SAM Fluorescent Immunoassay Market Impact Analysis of Driver and Restraints
Figure 8. SAM Fluorescent Immunoassay Market - Revenue Forecast and Analysis
Figure 9. SAM Fluorescent Immunoassay Market Share by Product Type - 2021 & 2028 (%)
Figure 10. SAM ELISA: Fluorescent Immunoassay Market Revenue and Forecasts To 2028 (USD Million)
Figure 11. SAM Rapid Lateral Flow Immunoassay: Fluorescent Immunoassay Market Revenue and Forecasts To 2028 (USD Million)
Figure 12. SAM Others: Fluorescent Immunoassay Market Revenue and Forecasts To 2028 (USD Million)
Figure 13. SAM Fluorescent Immunoassay Market Share by Application - 2021 & 2028 (%)
Figure 14. SAM Infectious Diseases: Fluorescent Immunoassay Market Revenue and Forecasts To 2028 (USD Million)
Figure 15. SAM Oncology: Fluorescent Immunoassay Market Revenue and Forecasts To 2028 (USD Million)
Figure 16. SAM Cardiovascular Disease: Fluorescent Immunoassay Market Revenue and Forecasts To 2028 (USD Million)
Figure 17. SAM Others: Fluorescent Immunoassay Market Revenue and Forecasts To 2028 (USD Million)
Figure 18. SAM Fluorescent Immunoassay Market Share by End User - 2021 & 2028 (%)
Figure 19. SAM Hospitals & Clinics: Fluorescent Immunoassay Market Revenue and Forecasts To 2028 (USD Million)
Figure 20. SAM Diagnostic Centers: Fluorescent Immunoassay Market Revenue and Forecasts To 2028 (USD Million)
Figure 21. SAM Pharmaceutical & Biotechnology Companies: Fluorescent Immunoassay Market Revenue and Forecasts To 2028 (USD Million)
Figure 22. SAM Academic & Research Institutes: Fluorescent Immunoassay Market Revenue and Forecasts To 2028 (USD Million)
Figure 23. SAM Others: Fluorescent Immunoassay Market Revenue and Forecasts To 2028 (USD Million)
Figure 24. SAM Fluorescent Immunoassay Market Revenue Overview, by Country, 2021 (US$ Million)
Figure 25. SAM Fluorescent Immunoassay Market Revenue and Forecasts to 2028, By Country (%)
Figure 26. Brazil: Fluorescent Immunoassay Market Revenue and Forecasts to 2028 (USD Million)
Figure 27. Argentina Fluorescent Immunoassay Market Revenue and Forecasts to 2028 (USD Million)
Figure 28. Rest of SAM: Fluorescent Immunoassay Market- Revenue and Forecast to 2028 (USD Mn)List of Tables
Table 1. SAM Fluorescent Immunoassay Market -Revenue and Forecast to 2028 (USD Million)
Table 2. Brazil: Fluorescent Immunoassay Market, by Product Type - Revenue and Forecast to 2028 (USD Million)
Table 3. Brazil: Fluorescent Immunoassay Market, by Application - Revenue and Forecast to 2028 (USD Million)
Table 4. Brazil: Fluorescent Immunoassay Market, by End User - Revenue and Forecast to 2028 (USD Million)
Table 5. Argentina: Fluorescent Immunoassay Market, by Product Type - Revenue and Forecast to 2028 (USD Million)
Table 6. Argentina: Fluorescent Immunoassay Market, by Application - Revenue and Forecast to 2028 (USD Million)
Table 7. Argentina: Fluorescent Immunoassay Market, by End User - Revenue and Forecast to 2028 (USD Million)
Table 8. Rest of SAM: Fluorescent Immunoassay Market, by Product Type - Revenue and Forecast to 2028 (USD Million)
Table 9. Rest of SAM: Fluorescent Immunoassay Market, by Application - Revenue and Forecast to 2028 (USD Million)
Table 10. Rest of SAM: Fluorescent Immunoassay Market, by End User - Revenue and Forecast to 2028 (USD Million)
Table 11. Organic Developments
Table 12. Inorganic Developments
Table 13. Glossary of Terms
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Abbott
- BD
- bioMerieux SA
- Danaher
- F. Hoffmann-La Roche Ltd.
- Ortho Clinical Diagnostics Holdings plc
- Quidel Corporation
- Siemens AG
- Sysmex Corporation
- Thermo Fisher Scientific Inc.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 153 |
| Published | August 2022 |
| Forecast Period | 2022 - 2028 |
| Estimated Market Value ( USD | $ 129.71 Million |
| Forecasted Market Value ( USD | $ 168.65 Million |
| Compound Annual Growth Rate | 3.8% |
![Immunodiagnostics Market Forecast to 2030 - Global Analysis by Product [Enzyme-Linked Immunosorbent Assays, Chemiluminescence Immunoassays, Radioimmunoassays, and Others], Clinical Indication, End User, and Geography - Product Image](http://www.researchandmarkets.com/product_images/12371/12371704_60px_jpg/immunodiagnostics_market.jpg)
